Every recall we track for Becton Dickinson & Co. — 129 in all — plus the complaints and injury reports the public filed about them.
Becton Dickinson recalls BD GasPak EZ Campy Pouch System (catalog 260685) due to potential low carbon dioxide levels in gas generating pouches for microbiology use. Affected lots may not function properly in lab settings.
Becton Dickinson recalls BD GasPak EZ CO2 Pouch Systems (catalog 260684) for microbiology use due to potential low carbon dioxide levels. Affected lots: 5303157, 5329857, 5329860.
Becton Dickinson recalls BD Kiestra Isolate Suspension Cuvette Array (Catalog No. 246100) due to 2D barcodes with formatting errors that prevent expiration date reading, causing instrument errors.
Becton Dickinson & Co. is a leading manufacturer of medical devices and laboratory equipment. This catalog provides an overview of their product range.
Becton Dickinson recalls BD MAX System for in vitro diagnostics due to potential unauthorized access to product service credentials, risking data confidentiality and security.
Becton Dickinson recalls BD BACTEC Blood Culture Systems with specific catalog numbers due to unauthorized access risks to product service credentials. Affected units may have compromised data security.
Becton Dickinson recalls Veritor Connect Software (Catalog 444881) due to unauthorized access risks to product data. Affected users should contact support for credential updates.
BD recalls BACTEC 9120 Blood Culture Systems with catalog numbers 445570 and 445702 due to potential unauthorized access to product service credentials. Affected units may have security vulnerabilities.
Becton Dickinson & Co. is a leading manufacturer of medical devices and laboratory equipment. Our product catalog includes a wide range of products for clinical research, diagnostics, and laboratory applications.
Becton Dickinson recalls software version 8.80+ for BD COR System Model 444829 due to potential false negative results. Affected users should contact for remedy.
Becton Dickinson recalls BD BACTEC MGIT 960 PZA Kit due to intermittent false resistance results for pyrazinamide in Mycobacterium tuberculosis susceptibility testing. Affected lots include 4150998, 4177908, and others.
Becton Dickinson recalls BD BBL TB Stain Kit K (Ref 212522) due to an expiration date mismatch between shipping and Certificate of Analysis. This may lead to using expired reagents.
Becton Dickinson recalls BD PCR Cartridges (model 437519) with potential signal drift in specific lots. Affected units have unique UDI numbers listed in the recall notice.
Becton Dickinson recalls BD BBL Sensi Disc Ampicillin 2 mcg (AM-2) test kits that may give false resistant results due to decreased potency. Affected lots expire by December 2024 to August 2025. Consumers should check their lot numbers.
Becton Dickinson recalls BD Phoenix M50 Automated Microbiology System Version 443624 (Catalog No: 443624) due to potential unauthorized access to product service credentials, risking data confidentiality and system integrity. Affected units include specific serial numbers listed in the recall notice.
Becton Dickinson recalls BACTEC 9120 System Version 445570 due to potential unauthorized access to product service credentials, risking data confidentiality and security.
Becton Dickinson recalls BD BACTEC FX40 Instrument Version 442296 (Catalog No: 442296) due to potential unauthorized access to product service credentials, risking data confidentiality and security. Affected units include specific serial numbers listed in the recall.
Becton Dickinson recalls BD COR PX Instrument model 443988 due to potential unauthorized access to product service credentials, risking data confidentiality and system integrity.
Becton Dickinson recalls BD EpiCenter Data Management System Version 440887 (Catalog No: 440887) due to potential unauthorized access to product service credentials, risking data confidentiality and security. Affected units include specific serial numbers listed in the recall.
Becton Dickinson recalls BD COR MX Instrument model 443989 due to potential unauthorized access to product service credentials, risking data confidentiality and system integrity. Affected units include specific serial numbers and catalog numbers.
Becton Dickinson recalls BACTEC 9240 System model 445475 due to potential unauthorized access to product service credentials, risking data confidentiality and security.
Becton Dickinson recalls BD EpiCenter Data Management System software version 440981 due to potential unauthorized access to product service credentials, risking data confidentiality and security. Affected units include specific serial numbers and catalog numbers listed in the recall.
Becton Dickinson recalls EpiCenter Single User Software version 441007 due to unauthorized access risks. Affected users should check their software version and take steps to secure credentials.
Becton Dickinson recalls BD BACTEC FX Instrument Top (Model 441385) due to potential unauthorized access to product service credentials, risking data confidentiality and security. Affected units have specific serial numbers listed in the recall.
Becton Dickinson recalls BD MAX System (Model 441916) due to potential unauthorized access to product service credentials. Affected units may have security vulnerabilities that could compromise data confidentiality, integrity, or availability.
Becton Dickinson recalls laboratory software version 444150 due to potential unauthorized access to product credentials, risking data confidentiality and security. Affected users should contact support for credential updates.
Becton Dickinson recalls BD COR GX Instrument model 443990 due to potential unauthorized access to product data. Affected units have specific serial numbers and catalog numbers. No action is required but security credentials should be updated.
Becton Dickinson recalls Synapsys Informatics software versions 4.20, 4.30, 5.10, 5.20, and 5.30 for IVD labs. These versions may show incorrect antibiotic susceptibility results, risking ineffective treatment or prolonged therapy.
Becton Dickinson recalls BD Phoenix 100 instruments that may misidentify E. coli, leading to incorrect treatment. Affected units have specific serial numbers and catalog numbers.
Becton Dickinson recalls BD Phoenix M50 instruments that may misidentify E. coli, leading to incorrect treatment. Affected units have specific software versions and serial numbers.
Becton Dickinson recalls BD BACTEC MGIT 960 PZA Kit for potential false resistant results in TB testing. Affected units have specific lot numbers and catalog codes. Contact for remedy.
Becton Dickinson recalls BD Kiestra Urine Culture Application with potential for inaccurate colony counts, risking patient diagnosis errors. Affected units have specific serial numbers.
Becton Dickinson recalls specific SARS-CoV-2 reagents for BD MAX systems due to potential false negative results from enzyme activity issues. Affected lots expire by August 2024.
Becton Dickinson recalls BD Phoenix NMIC-306 panels due to potential drug cross contamination, which may lead to incorrect or absent antibiotic treatment. Affected units were sold with specific lot numbers and expiration dates.
Becton Dickinson recalls BD Phoenix Yeast ID Panels due to esculin in A17 well causing system to abort tests. Affected units have specific UDI-DI and expiration dates.
Becton Dickinson recalls BD BBL Sensi Disc Clarithromycin-15 ug for possible inaccurate antibiotic susceptibility testing, risking delayed treatment or wrong antibiotic choices.
Becton Dickinson recalls BD BBL Sensi Disc Ampicillin with Sulbactam 10/10 mg (Catalog 231660) due to potential inaccuracies in antibiotic susceptibility testing for H. influenzae, which could lead to delayed diagnosis or inappropriate treatment.
Becton Dickinson recalls BD BBL Sensi Disc Doripenem 15 ug for potential accuracy issues in H. influenzae antibiotic testing, risking incorrect treatment decisions.
Becton Dickinson recalls BD BBL Sensi Disc Ceftriaxone-30 ug for possible accuracy issues in H. influenzae antibiotic testing, risking delayed treatment or wrong antibiotics.
Becton Dickinson recalls BD BBL Sensi Disc Cefuroxime-30 ug discs for possible inaccurate antibiotic susceptibility testing, risking delayed diagnosis or wrong treatment. Affected lots and catalog numbers listed.
Becton Dickinson recalls BD BBL Sensi Disc Ampicillin for possible accuracy issues in H. influenzae antibiotic testing, which could lead to delayed diagnoses or incorrect treatment.
Becton Dickinson recalls BD BBL Sensi Disc Cefixime discs for possible inaccurate antibiotic susceptibility testing, risking delayed treatment or wrong antibiotics. Affected lots: 2004492, 3010077, 3223406, 1305984, 2091014.
Becton Dickinson recalls BD BBL Sensi Disc Ofloxacin-5 ug for possible inaccuracy in H. influenzae antibiotic testing, risking delayed treatment or wrong antibiotics.
Becton Dickinson recalls BD BBL Sensi Disc Ceftazidime-30 ug discs for possible inaccurate antibiotic susceptibility testing, which could lead to delayed treatment or wrong antibiotic choices.
Becton Dickinson recalls BD BBL Sensi Disc Sulfamethoxazole with Trimethoprim 23.75/1.25 ug for possible inaccurate antibiotic susceptibility testing results, which could delay diagnosis or cause inappropriate treatment.
Becton Dickinson recalls BD BBL Sensi Disc Augmentin 3mg (Catalog 291270) for possible inaccurate antibiotic susceptibility testing, risking delayed treatment or wrong antibiotics. Affected lots not sold in US.
Becton Dickinson recalls BD BBL Sensi Disc Levofloxacin-5 ug for possible inaccurate antibiotic susceptibility testing, risking delayed diagnoses and improper treatment. Affected units include specific catalog numbers and lots.
Becton Dickinson recalls BD BBL Sensi Disc Aztreonam for possible inaccurate antibiotic susceptibility testing, risking delayed treatment or wrong antibiotics. Check catalog numbers 231640 and 231641.
Becton Dickinson recalls BD BBL Sensi Disc Ciprofloxacin-5 ug discs for possible accuracy issues in H. influenzae antibiotic testing, which could lead to delayed treatment or wrong antibiotic choices.
Becton Dickinson recalls BD BBL Sensi Disc Ertapenem-10 ug discs for possible inaccurate antibiotic susceptibility testing, which could lead to delayed treatment or wrong antibiotic choices.
Becton Dickinson recalls BD BBL Sensi Disc Chloramphenicol-30 ug discs for possible inaccurate antibiotic susceptibility testing, risking delayed diagnoses and inappropriate treatment. Affected lots listed in product description.
Becton Dickinson recalls BD BBL Sensi Disc Moxifloxacin 5 ug discs for possible inaccurate antibiotic susceptibility testing, which could lead to delayed treatment or wrong antibiotic choices.
Becton Dickinson recalls BD BBL Sensi Disc Imipenem-10 ug for possible inaccurate antibiotic susceptibility testing, risking delayed diagnosis and inappropriate treatment. Affected lots and catalog numbers listed.
Becton Dickinson recalls BD BBL Sensi Disc Cefepime discs for potential inaccuracy in H. influenzae antibiotic testing, which could lead to delayed diagnosis or inappropriate treatment. Affected units include specific catalog numbers and lots.
Becton Dickinson recalls BD BBL Sensi Disc Ceftaroline 30 ug for possible inaccurate antibiotic susceptibility testing, risking delayed treatment or wrong antibiotic choices.
Becton Dickinson recalls BD BBL Sensi Disc Meropenem-10 ug for possible inaccuracy in antibiotic susceptibility testing, risking delayed diagnoses and inappropriate antibiotic use. Affected units include specific catalog numbers and lots.
Becton Dickinson recalls BD BBL Sensi Disc Tetracycline 30 ug for possible inaccurate antibiotic susceptibility testing results, risking delayed diagnosis and improper treatment.
Becton Dickinson recalls BD BBL Sensi Disc Cefotaxime discs for possible inaccurate antibiotic susceptibility testing, risking delayed diagnosis and inappropriate antibiotic use. Affected lots and catalog numbers listed.
Becton Dickinson recalls BD BBL Sensi Disc Cefaclor for possible inaccuracy in H. influenzae antibiotic testing, risking delayed diagnosis and wrong treatment. Affected lots listed in product description.
Becton Dickinson recalls BD BBL Sensi Disc Minocycline 30 ug for possible inaccurate antibiotic susceptibility testing, which could delay diagnosis or cause inappropriate antibiotic use.
